|
Wednesday, November 22, 2023 |
|
健倍苗苗公布二零二四财年中期业绩 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「公司」;股份代号:2161,连同其附属公司统称「集团」) 为香港品牌保健品的领先营销商及分销商,集团今天公布截至二零二三年九月三十日止六个月(「报告期」)的中期业绩。 more info >> |
|
健倍苗苗公佈二零二四財年中期業績 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」) 為香港品牌保健品的領先行銷商及分銷商,集團今天公佈截至二零二三年九月三十日止六個月(「報告期」)的中期業績。 more info >> |
|
JBM Healthcare Announces FY2024 Interim Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2023 (the "Reporting Period"). more info >> |
|
Thursday, June 15, 2023 |
|
健倍苗苗公布二零二三财年全年业绩 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代号:2161,连同其附属公司统称「集团」)为香港品牌保健品的领先营销商及分销商,集团今天公布截至二零二三年三月三十一日止年度(「二零二三财年」或「报告期」)的全年业绩。 more info >> |
|
健倍苗苗公佈二零二三財年全年業績 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」)為香港品牌保健品的領先營銷商及分銷商,集團今天公佈截至二零二三年三月三十一日止年度(「二零二三財年」或「報告期」)的全年業績。 more info >> |
|
JBM Healthcare Announces FY2023 Annual Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period"). more info >> |
|
Friday, November 25, 2022 |
|
健倍苗苗公布二零二三财年中期业绩 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「集团」;股份代号:2161.HK) 为香港领先的品牌医疗保健品推广商及分销商,集团今天公布截至二零二二年九月三十日止六个月(「报告期」)的中期业绩。 more info >> |
|
健倍苗苗公佈二零二三財年中期業績 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「集團」;股份代號:2161.HK) 為香港領先的品牌醫療保健品推廣商及分銷商,集團今天公佈截至二零二二年九月三十日止六個月(「報告期」)的中期業績。 more info >> |
|
JBM Healthcare Announces FY2023 Interim Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Group"; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the interim results of the Group for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
Wednesday, June 15, 2022 |
|
万隆、雅各臣及健倍苗苗成立合资公司 拓展大中华区及亚洲专科药及品牌医疗保健市场 |
万隆控股集团有限公司(「万隆」,连同其附属公司「万隆集团」; 股份代号:0030.HK),其控股股东为云南白药集团股份有限公司(证券代号000538.SHE) more info >> |
|
|
|